Silihan lan utang jangka dawa perusahaan adagene.com (ADAG)

Adagene (ADAG) is implementing automated laboratory systems to accelerate the discovery of new molecules. Its operations rely on centers in the US and China that develop targeted therapies via AI. This chart of current share prices on GURU.Markets reflects the price action of an asset whose revenues are based on SAFEbody licensing royalties, while the separate_debt_long metric stands at 0.00.

To find a balance between asset quality and business valuation, analyzing long-term liabilities—which measure the total volume of loans with maturities exceeding one year and determine the level of financial leverage—is critical. Given Adagene (ADAG) high R&D expenditures in the absence of revenue, the changes in the corporation's long-term loans and borrowings on this chart reflect the issuer's degree of dependence on debt capital and external partners.